AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$12.77
+5.67%
Mkt Cap $3.83B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$14.75
Range $7.00 – $30.00
Implied Upside
+15.6%
Consensus $14.75 vs current $12.77
NASDAQ·Healthcare·Biotechnology
$12.77
+5.67%
Mkt Cap $3.83B
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$14.75
Range $7.00 – $30.00
+15.6%
Consensus $14.75 vs current $12.77